Features | Partner Sites | Information | LinkXpress
Sign In
VIEWORKS
Advantech Europe
Schiller

New “Bank” Adds Genomics Service to Patient Care

By HospiMedica International staff writers
Posted on 07 Mar 2013
A new company is offering a “gene vault” service for doctors who need a better way to store, protect, and share genomic data.

Coriell Life Sciences (Camden, NJ, USA), a startup company that grew out of a partnership between the Coriell Institute for Medical Research (Camden, NJ, USA) and IBM (Armonk, NY, USA) is offering a service to facilitate sequencing a patient’s DNA—through existing sequencing companies such as Illumina (San Diego, CA, USA) or Ion Torrent—and store it in its so-called gene vault, and also act as the middleman between doctors and companies that offer interpretation services.

The cloud-based workflow could help doctors in different locations take advantage of expert interpretations anywhere, analyzing a patient’s genome for DNA variants linked to poor drug response at one point, and later on, for example, order another for variants linked to heart disease. The company will also use a board of scientific advisors to guide them as to the best interpretation programs available. Since keeping the genomic data secure is a key component of the venture, the data will be stored at IBM headquarters and would be available only to limited users. If a patient changes a health-care provider, the data will remain available for the next physician.

“The intent is that the doctor would order a test like any other diagnostic test they order today,” said Scott Megill, president of Coriell Life Sciences. “We will return the genetic result in the human readable form back to the electronic medical record so the doctor can read it and interpret it for the patient.”

“No one company is in position to interpret the entire genome for its meaning,” said Michael Christman, CEO of the Coriell Institute for Medical Research. “But by having one’s sequence in the gene vault, then the physician will be able to order interpretative engines, analogous to apps for the iPhone.”

Whole genome sequencing is a laboratory process that determines the complete DNA sequence of an organism's genome at a single time. Almost any biological sample containing a full copy of the DNA can provide the material necessary for full genome sequencing. Such samples may include saliva, epithelial cells, bone marrow, or anything else that has DNA-containing cells. Because the sequence data that is produced can be quite large (for example, there are approximately six billion base pairs in each human diploid genome), genomic data is stored electronically and requires a large amount of computing power and storage capacity.

Related Links:

Coriell Institute for Medical Research
IBM
Illumina




Channels

Critical Care

view channel

Arm Approach Safer for Cardiac Catheterization

Patients undergoing a coronary angiogram had a significantly lower risk of major bleeding and death when accessed through the arm rather than the groin, according to a new study. Researchers at Erasmus University Medical Center (Rotterdam, The Netherlands) randomized more than 8,400 angiogram patients at 78 hospitals... Read more

Surgical Techniques

view channel
Image: The Percuvance Percutaneous Surgical System (Photo courtesy of Teleflex).

New Laparoscopic System Makes Trocar Use Redundant

A novel percutaneous surgical system does not require introductory trocars, thus leaving only a tiny mark on the patient’s skin following the procedure. The Percuvance Percutaneous Surgical System is... Read more

Women's Health

view channel

Women Undergoing Heart Attack Delay Hospital Arrival

Women suffering a heart attack wait much longer than men to call emergency medical services and face significantly longer delays getting to a hospital, according to a new study. Researchers at the University of Bologna (Italy) examined records of 7,457 European patients enrolled from 2010 to 2014 in an international... Read more

Business

view channel

New Hepatitis C Drugs Entail Economic Burden

The cost of treating people infected with the Hepatitis C virus (HCV) with newly approved therapies will likely place a tremendous strain on the US healthcare system. Researchers at The University of Texas MD Anderson Cancer Center (Houston, TX, USA) conducted a cost-effectiveness analysis using a microsimulation... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.